Skip to main navigation Skip to search Skip to main content

Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation

  • Shoshana Revel-Vilk*
  • , Ute Fischer
  • , Bärbel Keller
  • , Schafiq Nabhani
  • , Laura Gámez-Díaz
  • , Anne Rensing-Ehl
  • , Michael Gombert
  • , Andrea Hönscheid
  • , Hani Saleh
  • , Avraham Shaag
  • , Arndt Borkhardt
  • , Bodo Grimbacher
  • , Klaus Warnatz
  • , Orly Elpeleg
  • , Polina Stepensky
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Abstract

Mutations in LPS-responsive and beige-like anchor (. LRBA) gene were recently described in patients with combined immunodeficiency, enteropathy and autoimmune cytopenia. Here, we extend the clinical and immunological phenotypic spectrum of LRBA associated disorders by reporting on three patients from two unrelated families who presented with splenomegaly and lymphadenopathy, cytopenia, elevated double negative T cells and raised serum Fas ligand levels resembling autoimmune lymphoproliferative syndrome (ALPS) and one asymptomatic patient. Homozygous loss of function mutations in LRBA were identified by whole exome analysis. Similar to ALPS patients, Fas mediated apoptosis was impaired in LRBA deficient patients, while apoptosis in response to stimuli of the intrinsic mitochondria mediated apoptotic pathway was even enhanced. This manuscript illustrates the phenotypic overlap of other primary immunodeficiencies with ALPS-like disorders and strongly underlines the necessity of genetic diagnosis in order to provide early correct diagnosis and subsequent care.

Original languageEnglish
Pages (from-to)84-92
Number of pages9
JournalClinical Immunology
Volume159
Issue number1
DOIs
StatePublished - 1 Jul 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Inc.

Keywords

  • Autoimmune lymphoproliferative disorder
  • Immunodeficiency

Fingerprint

Dive into the research topics of 'Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation'. Together they form a unique fingerprint.

Cite this